Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Alain César Biraboneye"'
Publikováno v:
ChemMedChem
ChemMedChem, Wiley-VCH Verlag, 2010, 5, pp.79-85. ⟨10.1002/cmdc.200900418⟩
ChemMedChem, 2010, 5, pp.79-85. ⟨10.1002/cmdc.200900418⟩
ChemMedChem, Wiley-VCH Verlag, 2010, 5, pp.79-85. ⟨10.1002/cmdc.200900418⟩
ChemMedChem, 2010, 5, pp.79-85. ⟨10.1002/cmdc.200900418⟩
Herein we report the synthesis and neuroprotective effects of new N-alkyl-1,2,4-oxadiazolidine-3,5-diones and their corresponding synthetic intermediates, N-alkylhydroxylamines and N-1-alkyl-3-carbonyl-1-hydroxyureas, in an in vitro model of ischemia
Autor:
Pamela Maher, Alain César Biraboneye, Jean-Louis Kraus, Slavica Krantic, Younes Laras, Sébastien Madonna
Publikováno v:
Journal of Medicinal Chemistry
Journal of Medicinal Chemistry, 2009, 52, pp.4358-4369
Journal of Medicinal Chemistry, American Chemical Society, 2009, 52, pp.4358-4369
Journal of Medicinal Chemistry, 2009, 52, pp.4358-4369
Journal of Medicinal Chemistry, American Chemical Society, 2009, 52, pp.4358-4369
The ganglioside GM1 has neuroprotective effects but is not of therapeutic value because of its lack of bioavailability. Thus, molecules that mimic GM1 represent a novel approach to neuroprotection. We have synthesized 19 small GM1-like analogues whos
Publikováno v:
Translational Stroke Research ISBN: 9781441995292
Epidemiological, clinical, and biochemical studies have shown that various types of dietary fatty acids can modify the risk of stroke suggesting that fatty acids might be a good starting point for the development of new neuroprotective compounds for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a06bbcaca0283dfdf73cd8ddffebb24e
https://doi.org/10.1007/978-1-4419-9530-8_19
https://doi.org/10.1007/978-1-4419-9530-8_19
Autor:
Alain César Biraboneye, Sébastien Madonna, Younes Laras, Slavica Krantic, Pamela Maher, Jean-Louis Kraus
Publikováno v:
Journal of Medicinal Chemistry; Jul2009, Vol. 52 Issue 14, p4358-4369, 12p